Ramhari Kumbhar

Research associate

Johns Hopkins University School of Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (4)

Evidence links air pollution to dementia, yet its role in Lewy body dementia (LBD) remains unclear. In this work, we showed in a cohort of 56.5 million individuals across the United States that fine particulate matter (PM 2.5 ) exposure raises LBD risk. Mechanistically, we found that PM 2.5 exposure led to brain atrophy in wild-type mice, an effect not seen in α-synuclein (αSyn)–deficient mice. PM 2.5 exposure generated a highly pathogenic αSyn strain, PM 2.5 –induced preformed fibril (PM-PFF), with enhanced proteinase K resistance and neurotoxicity, resembling αSyn LBD strains. PM 2.5 samples from China, the United States, and Europe consistently induced proteinase-resistant αSyn strains and in vivo pathology. Transcriptomic analyses revealed shared responses between PM 2.5 -exposed mice and LBD patients, underscoring PM 2.5 ’s role in LBD and stressing the need for interventions to reduce air pollution and its associated neurological disease burden.

Year:

2025

Pathologic α-synuclein (α-syn) spreads from cell-to-cell, in part, through binding to the lymphocyte-activation gene 3 (Lag3). Here we report that amyloid β precursor-like protein 1 (Aplp1) interacts with Lag3 that facilitates the binding, internalization, transmission, and toxicity of pathologic α-syn. Deletion of both Aplp1 and Lag3 eliminates the loss of dopaminergic neurons and the accompanying behavioral deficits induced by α-syn preformed fibrils (PFF). Anti-Lag3 prevents the internalization of α-syn PFF by disrupting the interaction of Aplp1 and Lag3, and blocks the neurodegeneration induced by α-syn PFF in vivo. The identification of Aplp1 and the interplay with Lag3 for α-syn PFF induced pathology deepens our insight about molecular mechanisms of cell-to-cell transmission of pathologic α-syn and provides additional targets for therapeutic strategies aimed at preventing neurodegeneration in Parkinson’s disease and related α-synucleinopathies.

Year:

2024

The spread of prion‐like protein aggregates is a common driver of pathogenesis in various neurodegenerative diseases, including Alzheimer's disease (AD) and related Tauopathies. Tau pathologies exhibit a clear progressive spreading pattern that correlates with disease severity. Clinical observation combined with complementary experimental studies has shown that Tau preformed fibrils (PFF) are prion‐like seeds that propagate pathology by entering cells and templating misfolding and aggregation of endogenous Tau. While several cell surface receptors of Tau are known, they are not specific to the fibrillar form of Tau. Moreover, the underlying cellular mechanisms of Tau PFF spreading remain poorly understood. Here, it is shown that the lymphocyte‐activation gene 3 (Lag3) is a cell surface receptor that binds to PFF but not the monomer of Tau. Deletion of Lag3 or inhibition of Lag3 in primary cortical neurons significantly reduces the internalization of Tau PFF and subsequent Tau propagation and neuron‐to‐neuron transmission. Propagation of Tau pathology and behavioral deficits induced by injection of Tau PFF in the hippocampus and overlying cortex are attenuated in mice lacking Lag3 selectively in neurons. These results identify neuronal Lag3 as a receptor of pathologic Tau in the brain,and for AD and related Tauopathies, a therapeutic target.

Year:

2024

α-Synuclein (α-syn) strains can serve as discriminators between Parkinson’s disease (PD) and related α-synucleinopathies. The relationship between α-syn strain dynamics and clinical performance as patients transition from normal cognition (NC) to cognitive impairment (CI) is not known. Here, we show that the biophysical properties and neurotoxicity of α-syn strains change as PD cognitive status transitions from NC to mild cognitive impairment (PD-MCI) and dementia (PD-D). Both cross-sectional and longitudinal analyses reveal distinct α-syn strains in PD patients correlating to their level of cognitive impairment. Machine learning (ML) was employed to achieve high classification accuracy. The combination of thioflavin T (ThT) maximal fluorescence intensity (mfi), max slope of rise curve (forming rate), lag time (t lag ), 20% time (t 20 ), and half-time (t 50 ), dynamic light scattering (DLS) (peak number, ½ peak size, ½ peak intensity) and neurotoxicity for model training yielded superior performance (90∼99% accuracy in the 4-and 2-classification schema) compared to individual features alone in classifying cognitive status. For the longitudinal study, DLS peak number emerged as the strongest predictor of cognitive transition (HR = 0.12, p = 0.002), with the optimal predictive model combining DLS peak number, sex, DLS peak 1 size, and DLS peak 2 polydispersity achieving high accuracy (C-index of 90%). This study presents evidence that individuals with PD have different α-syn strains correlating to their cognitive status and highlights the potential of α-syn strain dynamics to guide future diagnosis, management, and stratification of PD patients. One Sentence Summary Distinct features of α-syn strains change with cognitive decline in Parkinson’s disease and AI-based analysis incorporating these combined characteristics serves as a powerful predictive tool for PD clinical stratification. Abstract Figure TOC: α-Synuclein strain changes allied with cognitive changes in Parkinson’s disease. Cross-sectional and longitudinal studies show that α-syn strain features (Thioflavin T (ThT), Dynamic light scattering (DLS), and neurotoxicity) change with and before cognitive decline in PD. Machine learning greatly enhances the diagnostic ability to predict PD subtypes and cognitive status.

Year:

2024

Collaborators (16)

Donghoon Kim

Assistant Professor

Dong-A University

SOUTH KOREA
View details

Minhan Park

Georgia Institute of Technology

UNITED STATES
View details

Mina Ryten

University College London

UNITED KINGDOM
View details

Xuan Zhang

Assistant Professor

University of California Merced

UNITED STATES
View details

Alexander Pantelyat

Associate Professor

Johns Hopkins University

UNITED STATES
View details

Valina Dawson

Professor

Johns Hopkins University School of Medicine

UNITED STATES
View details

Chan Hyun Na

Associate Professor

Johns Hopkins University School of Medicine

UNITED STATES
View details

Ted M. Dawson

Johns Hopkins University School of Medicine

UNITED STATES
View details

Nikolay Bliznyuk

University of Florida

UNITED STATES
View details

Rodney Weber

Georgia Institute of Technology

UNITED STATES
View details

Xiao Wu

Assistant Professor

Columbia University Mailman School of Public Health

UNITED STATES
View details

Xiaobo Mao

Associate Professor

Johns Hopkins University School of Medicine

UNITED STATES
View details

Shizhong Han

Lead Investigator

Johns Hopkins University School of Medicine

UNITED STATES
View details

david nauen

Johns Hopkins University School of Medicine

UNITED STATES
View details

Pengfei Liu

Georgia Institute of Technology

UNITED STATES
View details

Weiyi Peng

Director

University of Houston

UNITED STATES
View details